What is LOPJLB’s current signal on LITS?

LOPJLB’s latest quantitative signal on Lite Strategy, Inc. (LITS) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is LITS in?

Lite Strategy, Inc. (LITS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Lite Strategy, Inc. (LITS) do?

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San…

Where is Lite Strategy, Inc. based / listed?

Lite Strategy, Inc. is based in US, listed on NASDAQ.

Lite Strategy, Inc. (LITS)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.27+4.10%Close

BUYCRISIS · day 2

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 40
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-58.4%

REV YoY-

ROE-31.3%

EPS YoY-

ROA-166.7%

GROSS

NET

[VALUATION]

P/E TTM-0.15

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B1.17

P/FCF-

EV/EBITDA-3.47

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO5.74

ND/EBITDA-

BETA0.04

NET INCOME (TTM) < 0

Lite Strategy, Inc. (LITS)

Key stats

Prediction markets

FUNDAMENTALS

Company news